Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Definitive Healthcare Announces Expanded Solutions for Biopharma and Medical Device Companies

Increased Pharmacy Claims Data and New Physician Insights Will Enable Clients to Accelerate Go-To-Market Strategy

Definitive Healthcare announced significant enhancements to its solution suites for biopharma companies and medical device manufacturers. New real-time insights will help clients further leverage the industry’s most comprehensive, accurate solution to accelerate their go-to-market strategy.

The new capabilities include:

  • A three-fold increase in the prescription claims coverage available in the company’s Rx Claims Data expansion module;
  • Powerful new data and analytics on physician affiliations, including historical affiliations and affiliation strength; and
  • New insights on telemedicine adoption and utilization across more than two million healthcare professionals in the United States.

Recommended AI News : Relay Network Achieves HITRUST CSF Certification to Manage Risk, Improve Security Posture, and Meet Compliance Requirements

“Today’s increasingly complex healthcare marketplace requires both market context and market contacts,” said Jason Krantz, founder and CEO of Definitive Healthcare. “These new solutions provide life sciences clients with comprehensive market data to help them develop a go-to-market strategy, and then deliver the detailed account-level contact information needed to win deals.”

Related Posts
1 of 27,498

The expanded solutions will provide biopharma and medical device clients with better insight to target healthcare professionals and prescribers with profiles that are most aligned with a drug, therapy, or device.

Recommended AI News : InsurePay Secures $5 Million Series A Investment Round Led by FINTOP Capital

“As avid users of Definitive Healthcare, we are excited about the additional insight that will come from the expanded pharmacy claim data,” said Stan Alie, GPO National Account Director at Boehringer-Ingelheim Pharmaceuticals. “This data will help us navigate the ever-changing healthcare landscape and provide us with the information we need to make well-informed decisions for the patients we serve.”

Definitive Healthcare has more than tripled the company’s prescription drug claims database to cover nearly 250 million patient lives. This enhanced coverage will allow clients to evaluate market potential, allocate investment resources and fine-tune go-to-market planning.

“By harmonizing de-identified prescription claims data with provider data like procedure history & referral networks, our life sciences clients can make better and more informed decisions across a range of functions from market intelligence to managed markets to sales operations,” said Kate Shamsuddin Jensen, Chief Product Officer at Definitive Healthcare. “With this expanded dataset, Definitive Healthcare clients can leverage real-time analytics on prescriber volumes and behaviors to identify unique patterns.”

Recommended AI News : Ansys and Siemens Energy Enable Rapid and Cost-Effective Additive Manufacturing for Customers

Leave A Reply

Your email address will not be published.